Everence Capital Management Inc. Has $1.90 Million Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Everence Capital Management Inc. lifted its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 27.1% in the fourth quarter, Holdings Channel.com reports. The fund owned 72,610 shares of the pharmacy operator’s stock after purchasing an additional 15,500 shares during the quarter. Everence Capital Management Inc.’s holdings in Walgreens Boots Alliance were worth $1,896,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. Candriam Luxembourg S.C.A. boosted its stake in shares of Walgreens Boots Alliance by 0.5% in the 1st quarter. Candriam Luxembourg S.C.A. now owns 63,483 shares of the pharmacy operator’s stock valued at $2,842,000 after purchasing an additional 310 shares in the last quarter. Signet Financial Management LLC increased its holdings in shares of Walgreens Boots Alliance by 1.0% during the first quarter. Signet Financial Management LLC now owns 35,461 shares of the pharmacy operator’s stock worth $1,588,000 after buying an additional 334 shares in the last quarter. Cooper Financial Group raised its stake in shares of Walgreens Boots Alliance by 4.2% in the third quarter. Cooper Financial Group now owns 10,982 shares of the pharmacy operator’s stock valued at $244,000 after acquiring an additional 442 shares during the last quarter. New York Life Investment Management LLC grew its position in Walgreens Boots Alliance by 0.4% during the 3rd quarter. New York Life Investment Management LLC now owns 114,506 shares of the pharmacy operator’s stock worth $2,547,000 after acquiring an additional 499 shares during the last quarter. Finally, Laurel Wealth Advisors Inc. increased its holdings in Walgreens Boots Alliance by 5.1% during the 1st quarter. Laurel Wealth Advisors Inc. now owns 10,563 shares of the pharmacy operator’s stock valued at $473,000 after purchasing an additional 509 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on WBA shares. TheStreet upgraded Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a research note on Monday, January 8th. SVB Leerink reduced their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating on the stock in a research report on Monday, March 18th. UBS Group dropped their price objective on shares of Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating for the company in a research report on Wednesday, April 3rd. TD Cowen dropped their target price on Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating for the company in a research report on Wednesday, April 3rd. Finally, Morgan Stanley lowered their price objective on Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating for the company in a research report on Monday, April 1st. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $24.36.

Walgreens Boots Alliance Price Performance

NASDAQ WBA opened at $17.64 on Wednesday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.32 and a current ratio of 0.66. Walgreens Boots Alliance, Inc. has a 52-week low of $17.53 and a 52-week high of $36.14. The business has a 50 day simple moving average of $20.70 and a 200 day simple moving average of $22.02. The stock has a market cap of $15.22 billion, a price-to-earnings ratio of -2.52, a PEG ratio of 1.09 and a beta of 0.73.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, topping analysts’ consensus estimates of $0.82 by $0.38. The business had revenue of $37.05 billion for the quarter, compared to analyst estimates of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The firm’s quarterly revenue was up 6.3% on a year-over-year basis. During the same period last year, the business posted $1.16 earnings per share. Analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current fiscal year.

Insider Transactions at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, Director Valerie B. Jarrett purchased 4,456 shares of the firm’s stock in a transaction dated Monday, January 29th. The stock was bought at an average cost of $22.44 per share, with a total value of $99,992.64. Following the purchase, the director now directly owns 4,456 shares of the company’s stock, valued at $99,992.64. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. In related news, Director Valerie B. Jarrett acquired 4,456 shares of the firm’s stock in a transaction dated Monday, January 29th. The stock was bought at an average price of $22.44 per share, for a total transaction of $99,992.64. Following the acquisition, the director now directly owns 4,456 shares of the company’s stock, valued at $99,992.64. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Inderpal S. Bhandari bought 3,000 shares of the company’s stock in a transaction that occurred on Thursday, April 11th. The shares were bought at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the acquisition, the director now directly owns 3,000 shares of the company’s stock, valued at approximately $54,150. The disclosure for this purchase can be found here. Insiders bought 13,456 shares of company stock valued at $270,423 over the last three months. Company insiders own 17.40% of the company’s stock.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.